President and CEO Kevin Sayer said the company will file for Medicare coverage of the G6, while it continues to work out an issue that prevents beneficiaries from using a feature that lets data be ...
Medical device maker DexCom announced Tuesday that the company has received a de novo clearance from the FDA to sell its latest continuous glucose monitoring system — the G6 — that requires no ...
Dexcom has received FDA approval for a continuous glucose monitor (CGM) that integrates with insulin pumps and other diabetes devices. The regulatory clearance marks the first time the FDA has signed ...
San Diego’s Dexcom posted a 30 percent jump in revenue for the March quarter as it prepares for a major launch of its next generation continuous glucose monitors that no longer requires finger pricks ...
Dexcom CGM to become a core part of Livongo’s solution for delivering personalized health insights and improved clinical outcomes to people with Diabetes MOUNTAIN VIEW, Calif. and SAN DIEGO, Jan. 13, ...
DexCom, Inc. DXCM recently announced that the Dexcom G6 continuous glucose monitoring (CGM) System has obtained CE Marking across Europe for attaching on the back of the upper arm, thereby offering ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British Columbia--(BUSINESS ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback